MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
293.78%
Quick Ratio
190.91%
Cash Ratio
87.35%
Debt to Asset Ratio
35.28%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Accounts receivable
    • Short-term bank deposits
    • Others
Liabilities Breakdown
    • Stockholders' equity
    • Total current liabilities
    • Total long-term liabilities
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
27,420
41,001
14,680
13,647
Short-term bank deposits
13,236
10,082
15,593
15,723
Restricted deposit
720
711
702
-
Accounts receivable
16,503
2,939
8,840
14,425
Other assets
2,049
1,149
1,129
1,452
Inventories
32,292
30,474
25,729
21,255
Total current assets
92,220
86,356
66,673
66,502
Funds in respect of employee rights upon retirement
-
589
578
549
Property and equipment, net
5,467
5,153
4,879
4,724
R&d grant receivable
2,100
-
-
-
Deferred income tax asset
2,374
2,445
2,516
2,679
Operating lease right of use assets
8,175
7,793
7,700
7,810
Total assets
110,336
102,336
82,346
82,264
Trade
6,506
4,285
5,259
5,375
Other
23,219
21,670
19,875
15,173
Operating lease liabilities
1,666
1,433
1,384
1,397
Total current liabilities
31,391
27,388
26,518
21,945
Liability for employee rights upon retirement
-
671
661
631
Operating lease liabilities
7,541
7,048
6,937
6,780
Total long-term liabilities
7,541
7,719
7,598
7,411
Total liabilities
38,932
35,107
34,116
29,356
Common stock, 0.001 par value authorized - as of december 31, 2024 and 2025, 185,000,000 shares issued and outstanding - as of december 31, 2024 and 2025, 75,850,275 and 80,425,981 shares, respectively
-
-
80
-
Additional paid-in capital
-
-
433,147
-
Accumulated deficit
-
-
-384,997
-
Stockholders' equity
71,404
67,229
48,230
52,908
Total liabilities and stockholders' equity
110,336
102,336
82,346
82,264
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Inventories$32,292K (52.82%↑ Y/Y)Cash and cashequivalents$27,420K (53.23%↑ Y/Y)Accounts receivable$16,503K (74.76%↑ Y/Y)Short-term bank deposits$13,236K (-14.62%↓ Y/Y)Other assets$2,049K (35.43%↑ Y/Y)Restricted deposit$720K Total current assets$92,220K (40.83%↑ Y/Y)Operating lease right ofuse assets$8,175K (63.60%↑ Y/Y)Property and equipment,net$5,467K (15.19%↑ Y/Y)Deferred income tax asset$2,374K (-13.29%↓ Y/Y)R&d grantreceivable$2,100K Total assets$110,336K (40.58%↑ Y/Y)Total liabilities andstockholders' equity$110,336K (40.58%↑ Y/Y)Stockholders' equity$71,404K (43.09%↑ Y/Y)Total liabilities$38,932K (36.21%↑ Y/Y)Total currentliabilities$31,391K (30.30%↑ Y/Y)Total long-termliabilities$7,541K (67.88%↑ Y/Y)Other$23,219K (45.76%↑ Y/Y)Trade$6,506K (-2.74%↓ Y/Y)Operating leaseliabilities$1,666K (13.18%↑ Y/Y)Operating leaseliabilities$7,541K (94.51%↑ Y/Y)

Protalix BioTherapeutics, Inc. (PLX)

Protalix BioTherapeutics, Inc. (PLX)